Wednesday, 14 October 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· October 26, 2025

More Rate Cuts Are Coming: Grab 6% High-Yield S&P 500 Stocks Now

View original at finance.yahoo.com
More Rate Cuts Are Coming: Grab 6% High-Yield S&P 500 Stocks Now Funtap / Shutterstock.com Investors love dividend stocks, especially those with high yields, because they provide a substantial income stream and offer significant total return potential…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Since 1926, dividends have accounted for approximately 32% of the S&P 500's total return, while capital appreciation has accounted for 68%

    80% confidence
  • Jefferies has a Buy rating and a $33 target price for Pfizer

    80% confidence
  • With the prospect of an October rate cut looking very positive, now is the time for investors to buy quality high-yield dividend stocks before the October 28-29 Federal Reserve meeting

    80% confidence
  • Goldman Sachs has a Buy rating and a $49 price target for Verizon

    80% confidence
  • UBS has a Buy rating with a $110 target price for UPS

    80% confidence
  • Investors love dividend stocks, especially those with high yields, because they provide a substantial income stream and offer significant total return potential

    80% confidence
  • Robert Baird has a Buy rating and a $102 target price for Alexandria Real Estate Equities

    80% confidence
  • Goldman Sachs has a Buy rating with a $72 target price for Altria

    80% confidence
  • Total return is one of the most effective ways to enhance the prospects of overall investing success

    80% confidence
  • Pfizer anticipates full-year 2025 revenues in the range of $61.0 billion to $64.0 billion

    80% confidence
  • Cutting Amazon shipping volume is part of UPS's broader strategy to focus on more profitable, less risky business segments

    80% confidence
  • Revenues from COVID-19 products in 2025 will be broadly consistent with 2024 levels, after excluding approximately $1.2 billion of non-recurring Paxlovid revenue in 2024

    80% confidence
  • Dividend stocks delivered an annualized return of 9.18% over the past half-century (1973 to 2023), more than double the annualized return for non-payers (3.95%)

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com
More Rate Cuts Are Coming: Grab 6% High-Yield S&P 500 Stocks Now — Source | Via News | ViaNews EU